{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:26:31Z","timestamp":1761823591510},"reference-count":29,"publisher":"Europa Digital & Publishing","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EuroIntervention"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.4244\/eijv9i5a92","type":"journal-article","created":{"date-parts":[[2013,9,23]],"date-time":"2013-09-23T14:13:36Z","timestamp":1379945616000},"page":"564-572","source":"Crossref","is-referenced-by-count":13,"title":["Current treatment and outcome of coronary in-stent restenosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)"],"prefix":"10.4244","volume":"9","author":[{"given":"Torsten","family":"Schwalm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Lagerqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2774","reference":[{"key":"key-2013930162737-0","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.ahj.2005.08.011","article-title":"Bare metal stent restenosis is not a benign clinical entity.","volume":"15","author":"Chen MS","year":"2006","journal-title":"Am Heart J."},{"key":"key-2013930162737-1","first-page":"401","article-title":"Clinical presentation of patients with in-stent restenosis in the drug-eluting stent era.","volume":"20","author":"Lee MS","year":"2008","journal-title":"J Invasive Cardiol."},{"key":"key-2013930162737-2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ccd.22278","article-title":"Clinical outcomes of drug-eluting versus bare-metal in-stent restenosis.","volume":"75","author":"Singh IM","year":"2010","journal-title":"Catheter Cardiovasc Interv."},{"key":"key-2013930162737-3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa032441","article-title":"A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.","volume":"350","author":"Stone GW","year":"2004","journal-title":"N Engl J Med."},{"key":"key-2013930162737-4","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.","volume":"349","author":"Moses JW","year":"2003","journal-title":"N Engl J Med."},{"key":"key-2013930162737-5","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.amjcard.2005.01.072","article-title":"Incidence and predictors of target vessel revascularization and clinical event rates of the sirolimus eluting coronary stent (results from the prospective multicenter German Cypher Stent Registry).","volume":"95","author":"Zahn R","year":"2005","journal-title":"Am J Cardiol."},{"key":"key-2013930162737-6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1161\/01.CIR.0000109138.84579.FA","article-title":"Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the \u201creal world\u201d: the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry.","volume":"109","author":"Lemos PA","year":"2004","journal-title":"Circulation."},{"key":"key-2013930162737-7","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.jacc.2008.08.025","article-title":"Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis: results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.","volume":"52","author":"Alfonso F","year":"2008","journal-title":"J Am Coll Cardiol."},{"key":"key-2013930162737-8","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00392-008-0682-5","article-title":"Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.","volume":"97","author":"Scheller B","year":"2008","journal-title":"Clin Res Cardiol."},{"key":"key-2013930162737-9","doi-asserted-by":"publisher","first-page":"703","DOI":"10.4244\/EIJV5I6A116","article-title":"Long-term clinical follow-up of drug-eluting stent restenosis treatment: retrospective analysis from two high volume catheterisation laboratories.","volume":"5","author":"Tagliareni F","year":"2010","journal-title":"EuroIntervention."},{"key":"key-2013930162737-10","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.jacc.2012.01.015","article-title":"A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: The PEPCAD-DES Study.","volume":"59","author":"Rittger H","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"key-2013930162737-11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jcin.2010.10.012","article-title":"Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis.","volume":"4","author":"Habara S","year":"2011","journal-title":"J Am Coll Cardiol Intv."},{"key":"key-2013930162737-12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.amjcard.2008.09.107","article-title":"Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.","volume":"103","author":"Steinberg DH","year":"2009","journal-title":"Am J Cardiol."},{"key":"key-2013930162737-13","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1056\/NEJMoa0809902","article-title":"Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden.","volume":"360","author":"James SK","year":"2009","journal-title":"N Engl J Med."},{"key":"key-2013930162737-14","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/eurheartj\/ehr479","article-title":"Lower risk of stent thrombosis and restenosis with unrestricted use of \u2018new-generation\u2019 drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR).","volume":"33","author":"Sarno G","year":"2012","journal-title":"Eur Heart J."},{"key":"key-2013930162737-15","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S0735-1097(03)00852-0","article-title":"A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis.","volume":"42","author":"Alfonso F","year":"2003","journal-title":"J Am Coll Cardiol."},{"key":"key-2013930162737-16","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1067\/mhj.2001.113998","article-title":"Treatment of focal in-stent restenosis with balloon angioplasty alone versus stenting: Short- and long-term results.","volume":"141","author":"Mehran R","year":"2001","journal-title":"Am Heart J."},{"key":"key-2013930162737-17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ccd.22509","article-title":"Drug-eluting stents versus bare-metal stents for treatment of bare-metal in-stent restenosis.","volume":"76","author":"Singh IM","year":"2010","journal-title":"Catheter Cardiovasc Interv."},{"key":"key-2013930162737-18","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1093\/eurheartj\/ehn231","article-title":"Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare-metal stent restenosis: the TAXUS V ISR trial.","volume":"29","author":"Ellis SG","year":"2008","journal-title":"Eur Heart J."},{"key":"key-2013930162737-19","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1056\/NEJMoa061254","article-title":"Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.","volume":"355","author":"Scheller B","year":"2006","journal-title":"N Engl J Med."},{"key":"key-2013930162737-20","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1161\/CIRCULATIONAHA.108.839282","article-title":"Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis.","volume":"119","author":"Unverdorben M","year":"2009","journal-title":"Circulation."},{"key":"key-2013930162737-21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.acvd.2009.01.004","article-title":"Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents.","volume":"102","author":"De Labriolle A","year":"2009","journal-title":"Arch Cardiovasc Dis."},{"key":"key-2013930162737-22","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.jacc.2010.07.028","article-title":"In-stent restenosis in the drug-eluting stent era.","volume":"56","author":"Dangas GD","year":"2010","journal-title":"J Am Coll Cardiol."},{"key":"key-2013930162737-23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/CIRCULATIONAHA.109.905802","article-title":"Sirolimus-eluting stent versus balloon angioplasty for sirolimus-eluting stent restenosis: Insights from the j-Cypher Registry.","volume":"122","author":"Abe M","year":"2010","journal-title":"Circulation."},{"key":"key-2013930162737-24","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/j.jacc.2006.02.046","article-title":"Drug-eluting stent restenosis the pattern predicts the outcome.","volume":"47","author":"Cosgrave J","year":"2006","journal-title":"J Am Coll Cardiol."},{"key":"key-2013930162737-25","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1016\/j.jacc.2010.02.009","article-title":"Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study.","volume":"55","author":"Mehilli J","year":"2010","journal-title":"J Am Coll Cardiol."},{"key":"key-2013930162737-26","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jcin.2012.03.017","article-title":"Implantation of a drug-eluting stent with a different drug (switch strategy) in patients with drug-eluting stent restenosis.","volume":"5","author":"Alfonso F.","year":"2012","journal-title":"J Am Coll Cardiol Intv."},{"key":"key-2013930162737-27","doi-asserted-by":"publisher","first-page":"444","DOI":"10.4244\/EIJV8I4A70","article-title":"Comparison of two drug-eluting balloons: a report from the SCAAR registry.","volume":"8","author":"Bondesson P","year":"2012","journal-title":"EuroIntervention."},{"key":"key-2013930162737-28"}],"container-title":["EuroIntervention"],"original-title":[],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T02:19:01Z","timestamp":1715998741000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.pcronline.com\/eurointervention\/64th_issue\/92"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["EIJV9I5A92"],"URL":"https:\/\/doi.org\/10.4244\/eijv9i5a92","relation":{},"ISSN":["1774-024X"],"issn-type":[{"value":"1774-024X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}